Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors

Bioorganic & Medicinal Chemistry
2017.0

Abstract

MTB lysine-ɛ-aminotransferase (LAT) was found to play a crucial role in persistence and antibiotic tolerance. LAT serves as a potential target in the management of latent tuberculosis. In present work we attempted to derivatize the benzothiazole lead identified through high throughput virtual screening of Birla Institute of Technology and Science in house database. For Structure activity relationship purpose 22 derivatives were synthesized and characterized. Among synthesized compounds, eight compounds were found to be more efficacious in terms of LAT inhibition when compared to lead compound (IC50 10.38±1.21µM). Compound 22 exhibits bactericidal action against nutrient starved Mycobacterium tuberculosis (MTB). It also exhibits significant activity in nutrient starvation model (2.9log folds) and biofilm model (2.3log folds).

Knowledge Graph

Similar Paper

Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents
European Journal of Medicinal Chemistry 2020.0
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Searching for New Cures for Tuberculosis: Design, Synthesis, and Biological Evaluation of 2-Methylbenzothiazoles
Journal of Medicinal Chemistry 2009.0
Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2012.0
Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
European Journal of Medicinal Chemistry 2015.0
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
ACS Medicinal Chemistry Letters 2017.0
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H37RV
Bioorganic & Medicinal Chemistry Letters 2011.0
2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies
European Journal of Medicinal Chemistry 2013.0